Norovirus, which causes gastroenteritis in humans, is an important food-borne pathogen worldwide. In an effort to discover an antiviral substance against norovirus, extracts from several seaweeds were evaluated for antiviral activity against feline calicivirus (FCV), which was used as a surrogate. The methanolic extract of Undaria pinnatifida exhibited the most significant antiviral activity and virucidal efficacy against FCV. The concentrations of the extract that reduced viral replication by 50% (EC 50 ) and resulted in the death of 50% of the host cells (CC 50 ) were 0.05 mg/mL and 1.02 mg/mL, respectively. The selectivity index, calculated from the ratio of the CC 50 and EC 50 was 20.4. No FCV infection of host cells occurred following a 1-h incubation in the presence of 12.50 mg/mL U. pinnatifida extract, indicating that the virus was completely inactivated by the extract treatment. The results obtained in this study will contribute to the development of a natural antiviral substance that will prevent food-borne disease caused by norovirus.
Introduction
Norovirus, previously known as "Norwalk-like virus" or "small round-structured virus," comprises a diverse group of non-enveloped RNA viruses of the family Caliciviridae (Widdowson et al., 2005) . Norovirus causes epidemic gastroenteritis in humans and is considered one of the most important food-borne pathogens in the world (Lopman et al., 2004; Bull et al., 2006) ; norovirus may be responsible for more than 80% of nonbacterial gastroenteritis reported to the Centers for Disease Control and Prevention (Fankhauser et al., 2002; Widdowson et al., 2005) . Norovirus transmission occurs through the feces or vomit of infected patients and person-to-person contact; ingestion of contaminated water, or raw or minimally cooked foods such as seafood, fruits, and vegetables; and via airborne droplets. In addition, norovirus has a high attack rate owing to a very low infective dose; 10-100 viral particles are needed to produce an active infection (Fankhauser et al., 2002; Blackburn et al., 2004; Lopman et al., 2004; Bull et al., 2006) . Norovirus has seasonal characteristics and is prevalent in the winter months, but its recent occurrence in the summer has caused public health concerns (Lopman et al., 2004) . Since norovirus cannot be grown in tissue culture, disinfection efficacy and inactivation studies have been performed using closely related viruses such as the feline calicivirus (FCV) (Bidawid et al., 2003) . As a result, norovirus is known to survive freezing, temperatures as high as 60°C, and low pH, and to be highly resistant to common disinfectants such as 70% ethanol and 1,000--5,000 ppm chlorine (Steinmann, 2004) . Chemical disinfectants used to control the virus are corrosive and irritants; as consumer awareness of food safety issues increases, natural disinfectants must be de-*Corresponding author: leems@pknu.ac.kr veloped to replace these chemical compounds.
Terrestrial microorganism-based discovery programs have been used over several decades to identify drugs from natural sources. Recently, attempts have been made to isolate novel bioactive metabolites from marine resources. Seaweeds exhibit potent antitumor (Faulkner, 2002; Topcu et al., 2003; Blunt et al., 2006) , antiviral (Santos et al., 1999; Mazumder et al., 2002; Barbosa et al., 2004) , antifungal (Kubanek et al., 2003), antimicrobial (Fenical and Paul, 1984; Mayer et al., 1993; Deslandes et al., 2000) , and other pharmaceutical activities (Kang et al., 2005; Moo-Puca et al., 2008) . In this study, we screened seaweed extracts for antiviral activities against norovirus using FCV as a surrogate.
Materials and Methods

Sample preparation
Seaweeds used in this study were purchased from a commercial market located in Gijang, Busan, Korea, in March 2009 (Table 1) . Each sample was dried at 40°C for 2 days and finely powdered. Each powdered sample (100 g) was extracted twice with 1 L of 70% methanol at 80°C for 3 h, and filtered. The combined filtrate was concentrated by rotary evaporation at 40°C. Concentrated extracts were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mg/mL and used for further study. supplemented with 10% heat-inactivated fetal bovine serum (FBS; GIBCO/BRL) and 100 U/mL penicillin-100 μg/mL streptomycin (Sigma-Aldrich, St. Louis, MO, USA) in 75 cm 2 tissue culture flasks and incubated at 37°C in 5% CO 2 . Cell monolayers at 80-90% confluence were subcultured every 2 days (Fig. 1) .
FCV was propagated in monolayers of CrFK cells to prepare a virus pool; CrFK cells were incubated at 37°C in 5% CO 2 for 120 min to allow for FCV adsorption, and 10 mL DMEM supplemented with 2% FBS was added to promote virus propagation. Virus-induced cytopathic effects (CPEs) were seen in nearly 90% of the CrFK monolayers following incubation at 37°C in 5% CO 2 for 16-24 h (Fig. 1) . The virus was harvested by freeze-thawing three times followed by the removal of cell debris via centrifugation (10 min, 1,800×g, 4°C). The FCV suspension was stored at -80°C in 0.5 mL aliquots until use.
MTT assay
CrFK cells were seeded in 96 well plates at 1.0× 10 4 cells/well and cultured for 48 h until confluence. They were treated with various concentrations of seaweed extracts and incubated for 24 h before cell viability assays were performed; cells treated with an equal volume of maintenance medium were controls. Cell cytotoxicity was determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay in which mitochondrial succinate dehydrogenase activity converts the tetrazolium salt (MTT) to the dark blue formazan. The culture medium was aspirated and 100 µL of MTT solution (2 mg/mL) was added to each well and incubated for 4 h. Following aspiration, the dark blue formazans were dissolved in DMSO (Kanto Chemical Co., Tokyo, Japan) and the absorbance of each well was measured at 540 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). The median cellular cytotoxicity concentration (CC 50 ) was the concentration of the extracts that resulted in the death of 50% of the CrFK cells.
Plaque reduction assay
The antiviral activity of seaweed extracts against FCV was determined by the plaque reduction assay. CrFK cells were cultured in 6-well plates at 4.0×10 5 cells/mL as described above. Growth medium was aspirated from each well, a FCV suspension with 200 plaque forming units (PFU) per well was inoculated into the CrFK cells, and the inoculated plates were incubated for 120 min at 37°C in 5% CO 2 . After infection by the virus, 4 mL of overlay medium, which consisted of equal volumes of 1.5% agarose and 2×DMEM containing serial dilutions of the seaweed extracts, was added to each well. The plates were left at room temperature to ensure overlay solidification. Once completely cooled, plates were incubated at 37°C for 24-48 h in 5% CO 2 . The monolayers were fixed for a minimum of 4 h with 3.7% formaldehyde. Overlay plugs were removed with a gentle stream of cold running tap water aimed at the edge of the well. The fixed cell monolayers were stained with 0.1% crystal violet solution for 20 min. Plaques were counted to determine the virus titers. Antiviral effective concentration was expressed as an EC 50 , defined as the concentration of the sample required to inhibit virus-induced CPEs by 50% (Yoon et al., 2000; Bidawid et al., 2003) .
Virucidal assay
The virus titer was estimated by the Reed-Muench method (Mahy and Kangro, 1996; Kampf et al., 2005) ; the virus infectivity titer was expressed as a TCID 50 , defined as the dose at which 50% of the tissue culture was infected. The virucidal activities of the seaweed extracts against FCV were determined using serial dilutions to determine the TCID50. Briefly, 500 µL of FCV suspension (10 5 PFU/mL) was exposed to 500 µL of serially diluted seaweed extracts at room temperature for different times (3, 5, 24 h), after which 100 µL of mixture was diluted into 900 µL of maintenance medium. The diluted mixture was added to a monolayer of CrFK cells in a 96-well plate, incubated at 37°C for 3-4 days in 5% CO 2 , and stained with crystal violet solution. The cultures were monitored for CPEs, and TCID 50 titers were determined with the endpoint dilution method. Untreated controls were virus suspension with maintenance medium instead of extract.
Results and Discussion
Cytotoxicity test
Cytotoxicity of each seaweed extract to CrFK cells was determined by the MTT assay. Serially diluted seaweed extracts (diluted six times by the two fold serial dilution method; maximum concentration 2.5 mg/mL) were added to wells containing CrFK cells. The amount of formazan crystal in the presence or absence of extract gave a measure of the cyto-toxicity of each extract. The seaweed extracts used in this study showed different cytotoxicities to CrFK cells ( Table 2 ). The Ecklonia stolonifera extract was the least cytotoxic (CC 50 =2.43 mg/mL) and the Laminaria japonica extract was the most cytotoxic (CC 50 =0.49 mg/mL). The Ecklonia cava and Undaria pinnatifida extracts had relatively low cytotoxicities (CC 50 =1.82 and 1.02 mg/mL, respectively).
Antiviral activity of seaweed extracts
Antiviral activities of the seaweed extracts against FCV were measured by the plaque reduction assay and expressed as EC 50 values, defined as the concentrations of the extracts that inhibited 50% of virus replication. The plaque formation caused by FCV in CrFK cells decreased as the concentrations of the seaweed extracts increased (Fig. 2) . The extract of U. pinnatifida showed the most antiviral activity; the EC 50 value at which the number of plaques decreased by 50% compared to the control was 0.05 mg/mL. Selectivity index (SI) for U. pinnatifida, cal-culated from the CC 50 and EC 50 values, was 20.4 (Table 2 ). This suggests that the U. pinnatifida extract could be a suitable antiviral agent for use against FCV. The extract of L. japonica also strongly inhibited plaque formation by FCV at low concentrations (0.17 mg/mL). However, the SI value of the L. japonica extract was the lowest of the four seaweed extracts as it was highly cytotoxic to the host cells. In this system, the L. japonica extract was not a suitable antiviral agent against FCV. The extracts of E. cava and E. stolonifera also exhibited low SI values although they were higher than that of the L. japonica Fig. 2 . Antiviral activity of seaweed extracts against feline calicivirus (FCV). FCV was infected into Crandall-Reese Feline kidney cells and incubated in the presence or absence of various concentration of seaweed extracts. Antiviral activity was expressed as a comparative inhibitory ratio to inhibit virus-induced cytopathic effect, plaque, compared with control cells. This experiment was performed as triplicate. Each value is the result of mean ± S.E. •, Ecklonia cava extract; ■, E. stolonifera extract; ▲, Laminaria japonica extract; ◆, Undaria pinnatifida extract. extract.
Virucidal efficacy
In CrFK cells infected with FCV, CPEs occur (Fig.  1) ; these may be reduced by an antiviral substance. We measured the virucidal effects of the seaweed extracts against FCV by mixing serially diluted extracts with a FCV suspended solution for different times and infecting CrFK cells with the reaction mixture. Virucidal activities of the seaweed ex-tracts against FCV were expressed as log TCID 50 /mL values and were dose-and time-dependent (Table 3) . TCID50, 50% tissue culture infectious dose; *neg, feline calicivirus are inactivated.
U. pinnatifida extract exhibited the strongest virucidal efficacy against FCV and seemed to inhibit the infectivity of FCV; no viral infection of CrFK cells was observed after 1, 3, and 5 h in the presence of 12.50, 6.25, 3.13, and 1.56 mg/mL of U. pinnatifida extract. L. japonica extract also exhibited strong virucidal efficacy against FCV. FCV was completely inactivated when incubated with 6.25 mg/mL and 12.50 mg/mL L. japonica for over 3 h, and with 3.13 mg/mL for over 5 h (Table 3) ; FCV was not completely inactivated at 1.56 mg/mL L. japonica extract. Virucidal efficacy of the E. cava extract against FCV was limited compared to those of U. pinnatifida and L. japonica even though the extract exhibited some virucidal activity. E. stolonifera extract did not completely inactivate FCV under our experimental conditions, even though a 2-log decrease in the viral TCID 50 /mL value occurred after treatment for 5 h at 12.50 mg/mL. An antiviral effect is assumed when a 4-log decrease occurs in the viral TCID 50 /mL value (Bellamy, 1995) . Extracts of L. japonica and U. pinnatifida caused a 5-log decrease in viral TCID 50 /mL values at ≥3.13 mg/mL, indicating that these extracts are effective agents that can be used to inhibit infection of host cells by FCV. A comparison of the SI values of U. pinnatifida (20.4) and L. japonica (2.88) suggest that the U. pinnatifida extract is more useful than that of L. japonica for controlling infection of host cells by FCV (Table 2 ). The virucidal efficacies of E. cava and E. stolonifera extracts were negligible.
We propose that natural antiviral substances can be used in place of chemical compounds for the effective control of norovirus. We investigated the antiviral activities of seaweeds against FCV as a surrogate for norovirus, and found that extracts of U. pinnatifida and L. japonica exhibited outstanding antiviral effects. Fucoidan is a polysaccharide derived from U. pinnatifida and L. japonica, which possesses antitumor, antiviral, and anticoagulant activities, and is effective against viruses like the herpes simplex virus and the human immunodeficiency virus (Hudson et al., 1998; Kang et al., 2005) ; future research will confirm if fucoidan also inactivates FCV. Our investigations characterizing the in vitro inactivation of FCV by natural compounds will contribute to the development of a natural antiviral substance for the prevention of food-borne diseases caused by norovirus.
